Get started

Cyclacel Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

CYCC chart

Key stats

Market capitalization
4.055MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.9184USD
Net income
−21.198MUSD
Revenue
—
Shares float
12.515M
Beta
1.93

About Cyclacel Pharmaceuticals, Inc.

Sector
Health Technology
CEO
Spiro Rombotis
Headquarters
Berkeley Heights
Website
cyclacel.com
Founded
1996
ISIN
US23254L6039

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. The company builds a biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Ideas

CYCCThe stock held up well in a weak market environment on Friday. Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) broke resistance, but it was during the first 15 minutes of the day, which is not a good time to trade. The stock ended the day at the previous day's closing price of 7.11, and registered an in
Long
CYCC: Bullish Pennant, confirmedBullish Pennant, confirmed Pros: Descending volume during formation PPS above 50MA and 200MA Golden cross circled in blue ATR Ascending R/R ratio above 8 RS above 0, and ascending Cons: 250RSI below 50 200MA Flat If confirmed, Target: PT = 13.31$
Long
CYCC Announces at-the-market $7 Million Strategic InvestmentCyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures Cyclacel Pharmaceuticals has entered into a definitive securities purchase agreement with Acorn Bioventures, LP, a biotech-focused fundamental investor. - Strategic investmen
interesting set upNumerous things interest my curiosity on CYCC. First. 50ma just crossed 100 ma on the 30 min. In past this has been followed by a spike. Volatility is lowest it have been as far back I as could go, this thing wants to explode. Up or down I don't know. This thing seems to have found a bottom, I mean

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers